Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;24(4):e13705.
doi: 10.1111/petr.13705. Epub 2020 Apr 22.

Human leukocyte antigen eplet mismatches and long-term clinical outcomes in pediatric renal transplantation: A pragmatic, registry-based study

Matthew P Sypek  1   2   3   4 , Steve Hiho  5 , Linda Cantwell  5 , Phil Clayton  4   6   7 , Peter Hughes  1   3 , Amelia K Le Page  8   9 , Joshua Kausman  2   10   11
Affiliations

Human leukocyte antigen eplet mismatches and long-term clinical outcomes in pediatric renal transplantation: A pragmatic, registry-based study

Matthew P Sypek et al. Pediatr Transplant. 2020 Jun.

Abstract

Background: HLA epitope-based matching offers the potential to improve immunological risk prediction and management in children receiving renal allografts; however, studies demonstrating the association between systems for defining epitope mismatches and clinical end-points are lacking in this population.

Methods: We conducted a pragmatic, retrospective, registry-based study of pediatric recipients of primary renal allografts in Victoria, Australia between 1990 and 2014 to determine the association between HLA EpMM and clinical outcomes including graft failure, re-transplantation and dnDSA formation.

Results: A total of 196 patients were included in the analysis with a median age of 11 years. Median follow-up period was 15 years during which time 108 (55%) primary grafts failed and 72 patients were re-transplanted. HLA class I but not class II EpMM was a significant predictor of graft failure on univariate analysis but not in adjusted models. EpMM was associated with reduced likelihood of re-transplantation in univariate but not adjusted analysis. Within the limitations of the study, class-specific EpMM was a strong predictor of dnDSA formation. Associations were stronger when considering only the subset of antibody-verified EpMM.

Conclusion: Associations between HLA EpMM and clinical outcomes in pediatric renal allograft recipients seen on univariate analysis were attenuated following adjustment for confounders. These findings are inconclusive but suggest that HLA EpMM may provide one tool for assessing long-term risk in this population while highlighting the need for further clinical studies.

Keywords: donor-specific antibodies; epitope; eplet; graft survival; human leukocyte antigen; re-transplantation; renal transplant.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

REFERENCES

    1. Tambur AR, Claas FHJ. Toward HLA epitope matching in clinical transplantation. Am J Transplant. 2013;13(12):3059-3060.
    1. Duquesnoy RJ. Should epitope-based HLA compatibility be used in the kidney allocation system? Hum Immunol. 2017;78(1):24-29.
    1. Filippone EJ, Farber JL. Humoral immunity in renal transplantation: Epitopes, Cw and DP, and complement-activating capability - an update. Clin Transplant. 2015;29(4):279-287.
    1. Picascia A, Grimaldi V, Napoli C. From HLA typing to anti-HLA antibody detection and beyond: The road ahead. Transplant Rev. 2016;30(4):187-194.
    1. Wiebe C, Nickerson P. Strategic use of epitope matching to improve outcomes. Transplantation. 2016;100(10):2048-2052.